Results 251 to 260 of about 274,907 (333)

Remolding Waste Liquid From the Zeolite Synthesis Process Into Wrinkled Dressings for Diabetic Wound Therapeutics With Immunomodulation

open access: yesENERGY &ENVIRONMENTAL MATERIALS, EarlyView.
Waste liquid from natural clay‐to‐zeolite synthesis is remolded into a metal‐wrinkled dressing showing outstanding hemostatic, antibacterial, and wound‐healing effects. Chronic wounds resulting from diabetes are among the most common complications in diabetic patients.
Hanlin Yao   +8 more
wiley   +1 more source

Commonalities of platelet dysfunction in heart failure with preserved ejection fraction and underlying comorbidities

open access: yesESC Heart Failure, Volume 12, Issue 2, Page 1013-1028, April 2025.
Abstract Heart failure with preserved ejection fraction (HFpEF) is characterized by a lack of a specific targeted treatment and a complex, partially unexplored pathophysiology. Common comorbidities associated with HFpEF are hypertension, atrial fibrillation, obesity and diabetes.
Giorgia D'Italia   +2 more
wiley   +1 more source

Prevalence, characteristics, and outcomes of patients with low baseline C-reactive protein in giant cell arteritis. [PDF]

open access: yesArthritis Res Ther
Pichon S   +8 more
europepmc   +1 more source

Causal correlations between inflammatory proteins and heart failure: A two‐sample Mendelian randomization analysis

open access: yesESC Heart Failure, Volume 12, Issue 2, Page 1374-1385, April 2025.
Abstract Aims Inflammation plays a critical role in both the development and progression of heart failure (HF), which is a leading cause of morbidity and mortality worldwide. However, the causality between specific inflammation‐related proteins and HF risk remains unclear.
Xian‐Guan Zhu   +9 more
wiley   +1 more source

Immuno‐haemostatic dysregulation in heart failure with preserved ejection fraction

open access: yesESC Heart Failure, EarlyView.
Abstract Aims Heart failure with preserved ejection fraction (HFpEF) is a complex condition with partially unclear pathophysiology, in which systemic inflammation is a central contributor to changes in cardiac structure and function. The contribution of non‐traditional immune effectors—such as platelets and coagulation—remains underexplored in HFpEF ...
Giorgia D'Italia   +13 more
wiley   +1 more source

Home - About - Disclaimer - Privacy